U.S. stock night market volatility: Zynex reported a loss of $42.9 million, liquidity crisis triggered a 3.23% drop in stock price during night trading

U.S. Stock Night Market Movements Zynex fell 3.23% in the night market. Based on recent key news: On November 17, Zynex announced its third-quarter financial report, showing a net loss of $42.9 million and a 73% year-over-year decline in revenue. The report indicated that the company's liquidity is severely constrained, raising significant doubts about its ability to continue as a going concern, leading to a drop in stock price. Source: Reuters On November 18, Zynex's management emphasized in the earnings call that order volumes are initially stabilizing and proposed a multi-faceted turnaround strategy, but also acknowledged significant risks related to liquidity and government investigations, which the market reacted to negatively. Source: Reuters On November 18, analysts rated Zynex as "Buy," but due to the legal and restructuring risks the company faces, the market remains cautious about its prospects. Source: Reuters The medical device industry faces policy and legal risks. Stocks with High Trading Volume in the Industry Intuitive Surgical fell 0.34% in the night market. Based on recent news: On November 20, Intuitive Surgical announced progress in its international expansion and growth in U.S. Ambulatory Surgery Centers (ASC). The company expects significant growth in these areas by deploying the refurbished Xi system. Additionally, the company is committed to innovation, launching new platforms such as multi-port, single-port, and Ion, demonstrating its scalable market prospects. These strategic initiatives and the company's leadership in innovation support analysts' positive outlook and buy rating. On November 18, Vahaticor Inc announced it secured $23 million in financing, with Intuitive Surgical participating in the deal. The company issued convertible preferred stock, reflecting its proactive stance on investment and expansion. On November 20, Intuitive Surgical's business extends beyond selling da Vinci surgical robots to include other related services and products, showcasing the diversity of its business model and ongoing growth potential. The medical device industry is performing well overall, with innovation and international expansion as key drivers. TransMedics fell 1.47% in the night market. Based on recent key news: On November 18, TransMedics President and CEO Waleed H. Hassanein reported on the acquisition of the company's common stock. This news may indicate that the management is optimistic about future developments; however, the market's mixed reaction led to a slight decline in stock price. Source: EDGAR System On November 18, TransMedics announced it would participate in the Piper Sandler Annual Healthcare Conference. Although such events typically help enhance the company's image and investor confidence, they failed to significantly boost the stock price in the short term. Source: PR Newswire No other significant news recently. The medical technology industry has been volatile lately and requires attention GE HealthCare rose 0.36% in after-hours trading. Based on recent key news: On November 20, GE Healthcare announced the acquisition of Intelerad for $2.3 billion in cash. This move aims to expand its presence in the cloud software and artificial intelligence sectors, and is expected to drive growth in the company's total revenue and adjusted EBITDA. Source: Zhitong Finance On November 18, Piper Sandler analyst Jason Bednar maintained a buy rating on GE Healthcare, with a target price of $91. The analyst's positive rating may provide support for the stock price. Source: TipRanks On November 21, although the acquisition of Intelerad may lead to a slight dilution of earnings per share in the short term, this impact is expected to be significantly mitigated through systematic cost-cutting measures. Source: Zhitong Finance The medical imaging industry is undergoing an AI transformation